Amicus Therapeutics, Inc. (LON:0HF9)
London
· Delayed Price · Currency is GBP · Price in USD 6.06
+0.14 (2.37%)
At close: Jul 3, 2025
Amicus Therapeutics Market Cap
Amicus Therapeutics has a market cap or net worth of 1.38 billion as of July 3, 2025. Its market cap has decreased by -41.31% in one year.
Market Cap
1.38B
Enterprise Value
1.52B
Revenue
420.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.06
Market Cap Chart
Since May 31, 2007, Amicus Therapeutics's market cap has increased from 162.11M to 1.38B, an increase of 748.52%. That is a compound annual growth rate of 12.54%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 161.11B |
| GSK plc | 56.40B |
| Haleon | 33.47B |
| Smith & Nephew | 9.69B |
| ConvaTec Group | 5.26B |
| Hikma Pharmaceuticals | 4.37B |
| HUTCHMED (China) | 1.97B |
| Oxford Nanopore Technologies | 1.42B |